Securian Asset Management, Inc Sarepta Therapeutics, Inc. Transaction History
Securian Asset Management, Inc
- $3.43 Billion
- Q3 2024
A detailed history of Securian Asset Management, Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 7,410 shares of SRPT stock, worth $808,505. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,410
Previous 7,510
1.33%
Holding current value
$808,505
Previous $1.19 Million
22.01%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
84MCall Options Held
1.99MPut Options Held
1.36M-
Black Rock Inc. New York, NY10.3MShares$1.13 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$978 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$683 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$476 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$466 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.55B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...